599 
Prevalence and Clinical Features of MAC Infection in HIV+ South African Children Attending Harriet Shezi Clinic, Chris Hani Baragwanath Hospital: A Retrospective Analysis
Lee Kleynhans*1, M Palmer1, A Goga1, M Yotebien2, and T Meyers1
1Harriet Shezi Clin, Chris Hani Baragwaneth Hosp, Johannesburg, South Africa and 2Columbia Univ, New York, NY, US
Background: Mycobacterium avium-intracellulare
complex (MAC) is
one of the commonest opportunistic infections in HIV+ adults
in the developed world. However, there are few reports on the presentation and prevalence of MAC
in children and no prevalence reports
of MAC in children from African settings.
Several studies claim that MAC occurs infrequently in the HIV-positive
population in Africa.
Methods: We
sought to describe the prevalence,
presenting features, and outcome of MAC in HIV+ children
attending Harriet Shezi Children’s Clinic,
Chris Hani Baragwanath Hospital, Soweto, Johannesburg. We retrospectively
reviewed 2158
records within our database of HIV+ children,
aged 6 weeks to 17 years,
attending the clinic between January 2004 and June 2007. We
defined MAC infection as: 2
culture-positive sputum specimens or 1 culture-positive
blood Bactec or biopsy specimen per child from an accredited national laboratory in the presence of symptoms suggestive of MAC
infection.
Results:
A total of 13 children (4
girls and 9 boys) were diagnosed with MAC infection, giving an overall clinic
prevalence of 0.6%. Among the cohort of children with CD4 percentage
<10% and a separate cohort with total CD4 count <100, prevalence was 1.5
% and 2.6 %, respectively. The median age of our case-series was 10 years
(Q1-Q3 5 to 13
years). The
commonest presenting symptoms were non specific—cough in 10 of 13
(77%), LOW in 8
of 9 (89%), fatigue in 8 of 11
(73%), and fever
in 7 of 13 (54%).
Symptoms suggestive of gastrointestinal
tract involvement were noted in 5 of 11
(45%) patients. Median expected weight for age at time of MAC diagnosis was
67%. The median total CD4 count at time of MAC presentation was 16 (range 1 to 61),
and median CD4 percentage was 1%
(range 0.16 to 8.16). At
the time of MAC diagnosis, 10
children (77%) were on ART, raising the
possibility that these infections may have occurred within the context of
immune reconstitution. Clinical features and outcomes of these children are discussed.
Conclusions: Although
not common, MAC infection does occur in our population and is associated with poor clinical outcomes. A high
index of suspicion for MAC infection is needed amongst HIV+
children with severe immune suppression
because early diagnosis and treatment may reduce associated morbidity and mortality.
|